Glenmark Pharma Q2 Results: Co posts Rs 355 crore net profit on robust sales growth

November 14, 2024

Glenmark Pharma reported Rs 340 crore net profit in Q2FY25 led by robust sales growth in India and Europe. The drugmaker reported a net loss of Rs 180 crore in the corresponding quarter of the previous year.

More To Explore

Learn With ETMarkets: Can retail SIPs replace FII flows as India’s market backbone?

Systematic Investment Plans (SIPs) reached an all-time high of ₹27,269 crore in June 2025, reinforcing retail investor confidence and providing liquidity support amid foreign outflows.

July 19, 2025

NSDL nears listing deadline: How does the institutional giant measure up to CDSL’s retail surge?

As NSDL nears its SEBI-mandated IPO deadline, investor focus sharpens on how the institutional depository stacks up against retail-friendly CDSL, which has surged 44% over

July 19, 2025

Advertiser Disclosure

Great-investor.com helps users across the globe to find out The latest news, Guides, and Info about finance and investments. Furthermore, our content and research teams do not participate in any advertising planning nor are they permitted access to advertising campaign data.

Disclaimer

It is our organization’s primary mission to provide reviews, commentary, and analysis that are unbiased and objective. While great-investor.com has some data verified by industry participants, it can vary from time to time. Operating as an online business, this site may be compensated through third party advertisers. Our receipt of such compensation shall not be construed as an endorsement or recommendation by great-investor.com, nor shall it bias our reviews, analysis, and opinions. Please see our General Disclaimers for more information

Top10 International FZ LLE | 17th Floor, Creative Tower | 4422 | Fujairah | TRN: 100608946800003